SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: Roland Kahn who wrote (5023)1/26/1998 1:54:00 PM
From: Tunica Albuginea  Respond to of 23519
 
Roland , to be honest, I don't know. Anyway in the upcoming companies' profit squeeze, it is customary to invest in defensive drug/healthcare stocks. Consider, Arbor Drugs (gg),Vivus,.......

Back tonite.

TA



To: Roland Kahn who wrote (5023)1/27/1998 6:59:00 AM
From: blankmind  Read Replies (1) | Respond to of 23519
 
-- Funny you mention short squeeze.

-- VVUS has gone from 40 to 10 - and the shorts never covered. At last count, they had over 10 mill shares shorted.

-- IMHO, 2 things can create a short squeeze:

1. Good 4th earnings -- which we got.

2. Short position still over 10 mill shares - which we'll know in the next day or two.

-- If VVUS breaks $20, and the climate is still positive, look for some serious gaps upward.

Out.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News